PD-L1 Positive, EGFR-Negative, ALK-Negative Metastatic
Non-small cell lung cancer (NSCLC) encompasses a diverse group of lung malignancies, with metastatic cases requiring tailored treatment strategies. Among these, patients with PD-L1 positive,
Non-small cell lung cancer (NSCLC) encompasses a diverse group of lung malignancies, with metastatic cases requiring tailored treatment strategies. Among these, patients with PD-L1 positive,